TEI-1194, sodium 6-[D-(-)-a-(coumarin-3-carboxamide)-phenylacetamide] penicillanate and TEI-2012, sodium 6-[D-(-)-a-(8-hydroxy-coumarin-3-carboxamide)-phenylacetamide] penicillanate are new semisynthetic penicillin derivatives both possessing a broad spectrum of in vitro antibacterial activities. Minimal inhibitory concentrations of both agents were compared with carbenicillin. TEI-1194 and TEI-2012 were clearly found to have more potent activities especially against Pseudomonas aeruginosa than carbenicillin. At a concentration at 6.25 ,ug/ml, 85-90% of a total of 50 strains of clinically isolated P. aeruginosa were inhibited by TEI-1194 and TEI-2012, whereas carbenicillin had no effect. Evaluation of the antibacterial activity against a series of mutants producing different levels of /I-lactamases and test of the susceptibilities to some /3-lactamases demonstrated that TEI-1194 and TEI-2012 had low susceptibility to various cephalosporinases. However, both compounds were susceptible to penicillinase from Klebsiella pneumoniae H-2 at a rate of about 15 % of penicillin-G taking its absolute rate as 100.
Recently, the opportunistic infectious diseases have progressively increased and become a serious problem in chemotherapy. These have been mainly brought about by various Gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coil, Enterobacter cloacae, Proteus spp. and Serratia marcescens, etc. Carbenicillin (CBPC), sulbenicillin (SBPC) and recently ticarcillin were developed for the purpose of effective treatment of P. aeruginosa-infections. The unfortunate emergence of bacteria possessing high resistance to CBPC''2' has stimulated the search for newer antibiotics.
It has been known that some attempts of modification of an amino group of ampicillin (ABPC) have led to an improval of the antibacterial activity, particularly, to Pseudomonas spp3'''5' In our laboratory, the synthesis of new a-carboxamide benzyl penicillin derivatives have been studied and the biological activities have been investigated. Among these derivatives, two new compounds, TEI-1194 and TEI-2012, having a coumarin carboxamide group at the a position of benzylpenicillin, have been demonstrated as possessing marked antipseudomonal activity compared with CBPC. In this study, the in vitro activities of TEI-1194 and TEI-2012 were tested against standard bacteria and also against 50 strains of clinically isolated P. aeruginosa. Furthermore, the levels of resistance to various /3-lactamases were evaluated, thereby making use of mutants producing different levels of fl-lactamase as reported in a previous papers'. 
Materials and Methods

Antibiotics
Media
Media employed in our study were as follows: Tryptosoya broth (TSB) was purchased from Nissui Pharmaceutical Co., Ltd., Japan.
Heart infusion broth (HIB) and heart infusion agar (HIA) were products of Eiken Chemical
Co., Ltd.
Strains
Strains stocked in our laboratory were used as standards except for E. coli K-12 ML1410
carrying RGN238 or RGN823 that were kindly supplied by T. SAWAI, Chiba University, Chiba, Japan. The clinical isolates of P. aeruginosa were gifts from the Kitasato Institute. Isolation and some properties of /3-lactamase-mutants used in this study have been reported in the preceding papers).
Determination of MICs
Minimal inhibitory concentrations (MICs) were determined by an agar dilution technique. Serial two-fold dilutions of freshly prepared antibiotic solutions were mixed with melted HIA and the mixture was poured into Petri dishes.
Plates were inoculated with one loopful of 10-2 -fold diluted overnight culture of organisms in TSB unless specially described. The MIC values (/cg/ml) were determined after 18-hour incubation at 37°C.
Determination of MBCs Minimal bactericidal concentrations (MBCs) were determined by a standard two-fold serial dilution method with HIB as follows: An overnight culture of each strain in HIB was diluted to a final concentration of 10° cells/ml or 106 cells/ml with HIB containing serial two-fold dilutions of antibiotics. MICs were determined after incubation at 37°C for 18 hours. One loopful of each culture tube in the MIC test series was inoculated onto antibiotic-free HIA plates, and, after incubation at 37°C for 18 hours, the minimal bactericidal concentrations (MBCs) were recorded as the minimal concentration of drug destroying the ability of treated bacteria to grow on HIA plates.
Stability to /J-Lactamase The enzyme preparations were prepared as follows: Seven ml of a culture in TSB of each strain was diluted 10-fold with the same broth and incubated at 37°C. Penicillin G was added to the culture of each strain in a final concentration of 2 mg/ml for the induction of /3-lactamase formation. After incubation for 3.0 hours, the grown cells were harvested and washed once with 0.1 M Na-phosphate buffer (pH 7.0). The cells were disrupted by ultrasonic oscillation. After centrifugation, the supernatant was used as crude enzyme. fl-Lactamase activity was determined by a modification of SARGENT'S method''" unless specially described.
Specific activity was expressed as units per mg of protein per hour. Cephalothin (CET) was used a substrate for /3-lactamase (cephalosporinase) from P. aeruginosa, E. cloacae or Serraria spp. For /3-lactamase (penicillinase) from K. pneumoniae, penicillin G (PCG) was used as a standard substrate. Susceptibility to /3-lactamase was expressed as a relative rate of the six /3-lactam substrates, taking the absolute rate of CET or PCG as 100.
Inhibition of /3-Lacta _mase The /3-lactamase assay by modified SARGENT'S method" was carried out in the presence of 10, 20, 50, 100 and 200 /!M of TEI-1194 or TEI-2012 or ABPC or CBPC as inhibitor. The activity was ex- pressed as a relative rate of the hydrolysis of CET or PCG, taking the absolute rate in inhibitor-free assay as 100.
Results and Discussion
Antibacterial Spectrum The spectrum of antibacterial activities of TEI-1194 and TEI-2012 against standard Gram-positive and Gram-negative organisms are shown in Table 1 (Fig. 2b) .
The antibacterial activity of GM was the highest in all the tested compounds, followed by TEI-2012, TEI-1194 and CBPC in that order.
Although the activities of TEI-2012 and TEI-1194 were highly effective agaist almost all the strains at a concentration of 2001tg/ml or less, 2 -3 % of strains of P . aeruginosa remained highly resistant to these agents (MIC, higher than 400,ug/ml).
Bactericidal Activity
The in vitro minimal bactericidal concentration (MBC) of TEI-2012 was compared with that of CBPC and ABPC. As shown in Table 2 , against P. aeruginosa IFO 3080, TEI-2012 seemed to possess more potent bactericidal activity than CBPC and ABPC. Similar results were 
Resistance to /3-Lactatnase
The relative rates of hydrolysis of TEI-1194 and TEI-2012 by cephalosporinases from P. aeruginosa I FO 3080-C, E. cloacae IFO 12937-C and Serratia G-18 were compared with those of CBPC and other agents (Figs. 3a, 3b and 3c) . According to the microiodometrical method of Nov1cK'°), TEI-1194 and TEI-2012 were slightly hydrolyzed by cephalosporinase from E. cloacae IFO 12937 C at a rate ranging from 0.1 to 0.25 % of CET taking the absolute rate of the latter as 100. The levels of resistance 
3.2°'
These tests were carried out by the method described in the text . On the other hand, penicillinase from K. pneutnoniae could hydrolyze TEI-1194 and TEI-2012 at a rate of about 15 taking the absolute rate of hydrolysis of PCG as 100 (Fig. 3d) . Susceptibility of various kinds of penicillinase mediated by R-plasmids remain to be elucidated and are now undertaken.
Inhibitory Effects of TEI-1194, TEI-2012 and Other Penicillins against
Some /3-Lactamases For the purpose of preliminary evaluation of the affinity of TEI-1194 and TEI-2012 to the /3-lactamase molecule, the inhibitory effects of both compounds were also examined. Various concentrations of TEI-1194 or TEI-2012 or ABPC or CBPC as inhibitory agent were added to the /3-lactamase assay system and the relative rate of hydrolysis of PCG as substrate was determined (Fig. 4) . CBPC and ABPC had inhibitory effects against the cephalosporinase produced from P. aeruginosa IFO 3080-C and E. cloacae IFO 12937-C (Figs. 4a, 4b ). CBPC and ABPC gave about 60'/". and 20% inhibition respectively at 50 /'M against cephalosporinase from P. aeruginosa IFO 3080-C (Fig. 4a) . As presented in Fig. 4b , about 90% and 20% inhibition were obtained at 50 /dM CBPC and ABPC respectively against the enzyme from E. cloacae IFO 12937-C. On the contrary, TEI-1194 and TEI-2012 had no inhibitory effects toward both enzymes even at 200 /CM (Figs. 4a, 4b) . However, TEI-1 194 and TEI-2012 had more potent inhibitory-effects against cephalosporinase from Serratia G-18 than CBPC but their effects were poorer than that of ABPC (Fig. 4c ). These tendencies are strikingly different from the results presented in Fig. 4a or 4b Table 3 .
In experiments with P. aeruginosa IFO 3080, 3080-C and 3080-L, the MICs of TEI-1194 and TEI-2012 were rather independent from the producibility of /3-lactamase, whereas those of ABPC, CBPC, CER and CET were considerably affected by the levels of /3-lactamase. In contrast to these results, E. cloacae IFO 12937-C produces a high level of cephalosporinase even without induction and its specific activity is much higher than that of the P. aeruginosa IFO 3080-C and P. aeruginosa Tid-53-C enzymes. Working with strains E. cloacae IFO 12937, IFO 12937-C and -L, the MICs of TEI-1194 and TEI-2012 seem to be controlled by the producibility of cephalosporinase. This is apparently in contrast to earlier results which had demonstrated a relatively low susceptibility of both agents to this cephalosporinase as well as to the enzyme from P. aeruginosa IFO 1080-C (Figs. 3a and 3b) .
The contradiction might be explained by the difference of specific activities of the enzymes. Actual- 
